Nxera Pharma Co (FRA:JSS) Institutional Ownership: 20.56% (As of Jul. 13, 2026)


FRA:JSS Nxera Pharma Co Ltd FRA:JSS
72 GF Score
Price €4.88
GF Value €7.07
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Institutional Ownership?

Nxera Pharma Co FRA:JSS +2.09% 72 Institutional Ownership is 20.56% as of Jul. 13, 2026. GuruFocus rates FRA:JSS with a GF Score™ of 72/100 and a GF Value™ of €7.07. The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nxera Pharma Co's institutional ownership is 20.56%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nxera Pharma Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nxera Pharma Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Nxera Pharma Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Institutional Ownership Chart

Nxera Pharma Co Historical Data

The historical data trend for Nxera Pharma Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 18.88 18.94 19.25 19.01 18.92 18.90 21.11 21.19 20.94 20.56
FRA:JSS
72GF Score
Nxera Pharma Co Ltd FRA:JSS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 20.56% mean?
Nxera Pharma Co (FRA:JSS) has a Institutional Ownership of 20.56% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Institutional Ownership too high?
Nxera Pharma Co's current Institutional Ownership is 20.56%. Overall, Nxera Pharma Co has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Institutional Ownership compare to VRTX and REGN?
Nxera Pharma Co's Institutional Ownership of 20.56% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Institutional Ownership is 20.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Nxera Pharma Co (FRA:JSS) has a current Institutional Ownership of 20.56%. The stock's GF Value™ is €7.07, compared to a current price of €4.88 — trading 31% below its estimated fair value. The current Institutional Ownership is 20.56%. Nxera Pharma Co's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Nxera Pharma Co (FRA:JSS), the current Institutional Ownership is 20.56% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (FRA:JSS) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of €4.88 is trading 31% below its estimated GF Value™ of €7.07.

Key valuation signals for FRA:JSS:

  • Institutional Ownership: 20.56%
  • GF Value™: €7.07 vs. price of €4.88 (31% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the FRA:JSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
72GF Score

Get the complete analysis for FRA:JSS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.88
Price
€7.07
GF Value